Results 221 to 230 of about 835,487 (342)

Transient Stability During Asymmetrical Faults

open access: yes, 2015
This research project has been conducted at RTE in order to study the transient stability after asymmetrical faults. When three-phase short-circuits occur in a network, almost all the electrical power is lost on the relevant line(s). Among all short-circuit types, it is the most drastic event and the issue has to be solved very quickly.
openaire   +1 more source

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket   +14 more
wiley   +1 more source

Stress-Induced Collapse and Reactivity of Nanobubbles in Water: Linking Pressure Dynamics to Interfacial Stability. [PDF]

open access: yesACS Omega
Atukuri S   +9 more
europepmc   +1 more source

Anti‐CD19 CAR T Cells in Autoimmune Encephalitis: Inflammation Controlled, Neurodegeneration Unchecked?

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos   +9 more
wiley   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi   +5 more
wiley   +1 more source

Advancing protein engineering via organic chemistry. [PDF]

open access: yesCommun Chem
Nithun RV, Singh M, Baransi A, Jbara M.
europepmc   +1 more source

Home - About - Disclaimer - Privacy